ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 674455 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 674455; 2) Community: the network communities that were significantly associated with the response to NSC 674455; 3) Molecule: the relationships between components within communities and NSC 674455; 4) MDR: the compounds that were significantly associated with the NSC 674455.

NSC Compound Enrichment Correlation
NSC 684459 7H-Pyrido[3,2-d][1]benzazepine-6-thione, 4-(4-bromo- phenyl)-5,6-dihydro-2-phenyl- 0.0115521552688258 -0.22172117
NSC 685014 Null 0.0115521552688258 0.40374731
NSC 698959 Null 0.0115521552688258 0.34769178
NSC 713608 Null 0.0115521552688258 0.37711787
NSC 716768 Null 0.0115521552688258 -0.066294585
NSC 725191 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol 0.0115521552688258 0.51985805
NSC 736164 pyrazoline derivative 0.0115521552688258 0.32309243
NSC 740385 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide 0.0115521552688258 0.58654798
NSC 756698 Clomiphene citrate (USAN) 0.0115521552688258 0.41752974
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0115521552688258 0.2639008
Total:85  Current:22    [First] [Prev] [Next] [Last]